Publication | Closed Access

Relative bioavailability and safety of aripiprazole lauroxil, a novel once-monthly, long-acting injectable atypical antipsychotic, following deltoid and gluteal administration in adult subjects with schizophrenia

Aripiprazole LauroxilPsychoactive DrugPsychiatryMedicinePsychotropic MedicationPsychopharmacologySchizophreniaGluteal AdministrationPharmacotherapyRelative BioavailabilityPharmacologyPsychotic DisorderDrug Discovery